Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV Antibodies | 5 | 2025 | 61 | 1.530 |
Why?
|
| HIV Envelope Protein gp41 | 5 | 2025 | 11 | 1.350 |
Why?
|
| Antibodies, Neutralizing | 5 | 2025 | 340 | 1.130 |
Why?
|
| HIV-1 | 6 | 2025 | 908 | 1.120 |
Why?
|
| Antibodies, Monoclonal | 3 | 2025 | 1505 | 0.650 |
Why?
|
| Machine Learning | 1 | 2025 | 587 | 0.590 |
Why?
|
| HIV Infections | 5 | 2025 | 3193 | 0.280 |
Why?
|
| Neutralization Tests | 2 | 2025 | 76 | 0.280 |
Why?
|
| Receptors, IgG | 3 | 2025 | 77 | 0.260 |
Why?
|
| Receptors, CCR5 | 1 | 2025 | 60 | 0.220 |
Why?
|
| Saponins | 1 | 2024 | 12 | 0.210 |
Why?
|
| Antibodies, Bispecific | 1 | 2025 | 68 | 0.210 |
Why?
|
| Adjuvants, Immunologic | 1 | 2024 | 243 | 0.190 |
Why?
|
| Models, Molecular | 2 | 2025 | 1598 | 0.180 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2025 | 435 | 0.170 |
Why?
|
| Repetitive Sequences, Amino Acid | 1 | 2021 | 19 | 0.170 |
Why?
|
| B-Lymphocytes | 1 | 2025 | 870 | 0.150 |
Why?
|
| Nanoparticles | 1 | 2024 | 517 | 0.130 |
Why?
|
| Cell Surface Display Techniques | 1 | 2017 | 13 | 0.130 |
Why?
|
| Enzyme Assays | 1 | 2017 | 25 | 0.130 |
Why?
|
| Antibodies, Viral | 1 | 2021 | 674 | 0.130 |
Why?
|
| Cystine-Knot Miniproteins | 1 | 2016 | 1 | 0.120 |
Why?
|
| Cell Adhesion Molecules | 1 | 2017 | 181 | 0.120 |
Why?
|
| Thebaine | 1 | 2015 | 1 | 0.120 |
Why?
|
| Integrins | 1 | 2016 | 90 | 0.110 |
Why?
|
| Protein Engineering | 1 | 2016 | 122 | 0.110 |
Why?
|
| Hydrocodone | 1 | 2015 | 18 | 0.110 |
Why?
|
| Genetic Engineering | 1 | 2015 | 88 | 0.110 |
Why?
|
| Immunoconjugates | 1 | 2016 | 138 | 0.100 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2017 | 666 | 0.100 |
Why?
|
| Oligopeptides | 1 | 2016 | 267 | 0.100 |
Why?
|
| Anti-HIV Agents | 1 | 2021 | 912 | 0.100 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2017 | 414 | 0.100 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2015 | 573 | 0.080 |
Why?
|
| HEK293 Cells | 2 | 2025 | 741 | 0.080 |
Why?
|
| Neoplasms | 2 | 2016 | 2906 | 0.080 |
Why?
|
| Animals | 7 | 2025 | 38030 | 0.060 |
Why?
|
| Humans | 9 | 2025 | 145474 | 0.060 |
Why?
|
| Mice | 4 | 2025 | 18329 | 0.060 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 2214 | 0.060 |
Why?
|
| CD4 Antigens | 1 | 2025 | 137 | 0.050 |
Why?
|
| Gene Knockout Techniques | 1 | 2025 | 119 | 0.050 |
Why?
|
| AIDS Vaccines | 1 | 2024 | 53 | 0.050 |
Why?
|
| CRISPR-Cas Systems | 1 | 2025 | 166 | 0.050 |
Why?
|
| Viral Load | 1 | 2025 | 526 | 0.050 |
Why?
|
| Membrane Lipids | 1 | 2022 | 82 | 0.050 |
Why?
|
| Immune Sera | 1 | 2021 | 77 | 0.040 |
Why?
|
| Antibody Affinity | 1 | 2021 | 60 | 0.040 |
Why?
|
| Virus Internalization | 1 | 2021 | 65 | 0.040 |
Why?
|
| Guinea Pigs | 1 | 2021 | 159 | 0.040 |
Why?
|
| Protein Binding | 2 | 2017 | 2238 | 0.040 |
Why?
|
| HIV Seropositivity | 1 | 2021 | 119 | 0.040 |
Why?
|
| Protein Domains | 1 | 2021 | 311 | 0.040 |
Why?
|
| Immunization | 1 | 2021 | 375 | 0.040 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2025 | 699 | 0.040 |
Why?
|
| Aminoacyltransferases | 1 | 2017 | 13 | 0.030 |
Why?
|
| Cysteine Endopeptidases | 1 | 2017 | 78 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2021 | 2129 | 0.030 |
Why?
|
| Immunoglobulin G | 1 | 2021 | 892 | 0.030 |
Why?
|
| Cytokines | 1 | 2024 | 2067 | 0.030 |
Why?
|
| Cell-Free System | 1 | 2016 | 53 | 0.030 |
Why?
|
| Immunoglobulin Fc Fragments | 1 | 2016 | 41 | 0.030 |
Why?
|
| Papaver | 1 | 2015 | 1 | 0.030 |
Why?
|
| Benzylisoquinolines | 1 | 2015 | 2 | 0.030 |
Why?
|
| Morphinans | 1 | 2015 | 8 | 0.030 |
Why?
|
| Codeine | 1 | 2015 | 7 | 0.030 |
Why?
|
| Cell Line | 1 | 2021 | 2823 | 0.030 |
Why?
|
| Drug Design | 1 | 2016 | 175 | 0.030 |
Why?
|
| Biosynthetic Pathways | 1 | 2015 | 24 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 2017 | 407 | 0.030 |
Why?
|
| Carbohydrate Metabolism | 1 | 2015 | 59 | 0.030 |
Why?
|
| Molecular Targeted Therapy | 1 | 2016 | 439 | 0.020 |
Why?
|
| Biological Products | 1 | 2016 | 257 | 0.020 |
Why?
|
| Cell Survival | 1 | 2016 | 1100 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2016 | 934 | 0.020 |
Why?
|
| Drug Delivery Systems | 1 | 2016 | 381 | 0.020 |
Why?
|
| Proteins | 1 | 2016 | 1023 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 2017 | 967 | 0.020 |
Why?
|
| Peptides | 1 | 2016 | 998 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2016 | 2507 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2016 | 3542 | 0.020 |
Why?
|
| Male | 1 | 2025 | 72842 | 0.010 |
Why?
|